As such, metformin could potentially exacerbate disease progression in rhodopsin RP patients with the P23H mutation and possibly other rhodopsin misfolding mutations, if they are prescribed for type II diabetes. The gene discussed is RHO; the disease is retinitis pigmentosa 1.